Real ChatGPT answer · index seedIEHtiLLWOGccompleteHealth and wellness · women's healthinformational
What are the key pharmacological differences between third and fourth-generation progestins used in online-prescribed birth control pills regarding thrombosis risk?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
What are the key pharmacological differences between third and fourth-generation progestins used in online-prescribed birth control pills regarding thrombosis risk?
3 real searches · 1 real-search pass
third generation fourth generation progestins venous thromboembolism risk drospirenone desogestrel levonorgestrel systematic review guidelineGoogle ↗
OBSERVED
CDC U.S. Medical Eligibility Criteria combined hormonal contraceptives venous thromboembolism progestin drospirenone levonorgestrelGoogle ↗
OBSERVED
EMA combined hormonal contraceptives risk blood clots levonorgestrel desogestrel gestodene drospirenoneGoogle ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
third generation fourth generation progestins venous thromboembolism risk drospirenone desogestrel levonorgestrel systematic review guideline Google ↗
CDC U.S. Medical Eligibility Criteria combined hormonal contraceptives venous thromboembolism progestin drospirenone levonorgestrel Google ↗
EMA combined hormonal contraceptives risk blood clots levonorgestrel desogestrel gestodene drospirenone Google ↗
- Combined hormonal contraceptives - referral · ema.europa.eu
- Combined hormonal contraceptives · ema.europa.eu
- Combined hormonal contraception and the risk of venous thromboembolism: a guideline (2016) | American Society for Reproductive Medicine · asrm.org
- Combined hormonal contraception and the risk of venous thromboembolism: a guideline (2016) | American Society for Reproductive Medicine · prod.asrm.org
- Hormonal therapies and venous thrombosis: Considerations for prevention and management · pmc.ncbi.nlm.nih.gov
- Recommendation tables - Medical eligibility criteria for contraceptive use · ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
third generation fourth generation progestins venous thromboembolism risk drospirenone desogestrel levonorgestrel systematic review guideline OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
CDC U.S. Medical Eligibility Criteria combined hormonal contraceptives venous thromboembolism progestin drospirenone levonorgestrel OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
EMA combined hormonal contraceptives risk blood clots levonorgestrel desogestrel gestodene drospirenone OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |